Clinical trials
Terminated Phase 1/2 Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Altor BioScience | 3 |
| Pfizer | 3 |
| Therapeutic Advances in Childhood Leukemia Consortium | 3 |
| Gilead Sciences | 2 |
| Incyte Corporation | 2 |
| M.D. Anderson Cancer Center | 2 |
| Radboud University Medical Center | 2 |
| University Health Network, Toronto | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Ajai Chari | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 73 |
| Lymphoma | 16 |
| Multiple Myeloma | 15 |
| Neoplasms | 13 |
| Leukemia, Myeloid, Acute | 11 |
| Lymphoma, Large B-Cell, Diffuse | 10 |
| Neoplasm Metastasis | 10 |
| Leukemia | 8 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Lymphoma, Non-Hodgkin | 7 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.